Drug details

Aponvie (aprepitant injectable emulsion)

type of Antiemetic Agents, NK1 Receptor Antagonists

Aponvie (aprepitant) is a substance P/neurokinin-1 (NK1) receptor antagonist, indicated for the prevention of postoperative nausea and vomiting (PONV) in adults.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• fever,
• fatigue,
• burning eyes,
• swelling around your eyes and lips,
• swelling in the eyes,
• abdominal cramping,
• sores in your mouth or throat,
• skin pain, and
• red or purple rash with blisters that peels

The following drugs are related to Aponvie, either as a replacement or used together:

• Anzemet Injection (dolasetron mesylate injection)
• Anzemet Tablets (dolasetron)
• Emend Capsules (aprepitant capsules)
• Compazine (prochlorperazine)
• Decadron (dexamethasone)
• Inapsine (droperidol)
• Emend Injection (fosaprepitant dimeglumine injection)
• Kytril (granisetron)
• Kytril Injection (granisetron hydrochloride)
• Reglan (metoclopramide)
• Reglan Injection (metoclopramide injection)
• Reglan ODT (metoclopramide orally disintegrating tablets)
• Varubi (rolapitant tablets)